- Home
- HOLX
HOLX
Hologic Inc.
as 10-17-2025 3:56pm EST
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
| Founded: | 1985 | Country: | United States |
| Employees: | N/A | City: | MARLBOROUGH |
| Market Cap: | 15.0B | IPO Year: | 1990 |
| Target Price: | $78.92 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 2.41 | EPS Growth: | -17.18 |
| 52 Week Low/High: | $51.90 - $84.39 | Next Earning Date: | 11-03-2025 |
| Revenue: | $4,038,900,000 | Revenue Growth: | 1.29% |
| Revenue Growth (this year): | 3.37% | Revenue Growth (next year): | 4.51% |
Stock Insider Trading Activity of Hologic Inc. (HOLX)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| MACMILLAN STEPHEN P | HOLX | Chairman, President and CEO | Sep 22 '25 | Sell | $66.83 | 138,358 | $9,266,117.92 | 1,350,742 |
Latest Hologic Inc. News
HOLX Breaking Stock News: Dive into HOLX Ticker-Specific Updates for Smart Investing
MT Newswires
5 days ago
Mizuho Adjusts Price Target on Hologic to $70 From $75, Maintains Outperform Rating
Zacks
8 days ago
Hologic (HOLX) Stock Moves -1.25%: What You Should Know
StockStory
9 days ago
1 Profitable Stock with Promising Prospects and 2 We Avoid
Zacks
13 days ago
How to Play HOLX Stock This Breast Cancer Awareness Month?
Zacks
16 days ago
HOLX Stock Gains on FDA & CE Approval for Automated Molecular GI Tests
Zacks
16 days ago
Why Hologic (HOLX) Outpaced the Stock Market Today
Business Wire
16 days ago
Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2025 on Monday, November 3, 2025
Simply Wall St.
17 days ago
Hologic (HOLX): Assessing Valuation Following Upbeat Earnings, Guidance Boost, and New Partnership Moves
Compare HOLX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HOLX Hologic Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.